This is consistent with a CCL2 gradient from ischemic to non-ischemic brain tissue to recruit microglial cells and with a pro-inflammatory role of CCL2 in the clinical situation of stroke that might contribute to secondary neuronal cell death. This evidence concerns the gene CCL2 and stroke disorder.